Where does Elanco Tiergesundheit AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Elanco Tiergesundheit AG ranks #14,585 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Elanco Tiergesundheit AG hold?

Elanco Tiergesundheit AG holds 20 US utility patents granted between 2017 and 2024, spanning 13 technology areas.

What is Elanco Tiergesundheit AG's Innovation Score?

Elanco Tiergesundheit AG has an Innovation Score of 31.7 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Elanco Tiergesundheit AG focus on?

Elanco Tiergesundheit AG's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 16 patents, ranking #1,230 of 6,058 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Elanco Tiergesundheit AG's patent grant rate increasing or decreasing?

Elanco Tiergesundheit AG's recent grant velocity is -46% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Elanco Tiergesundheit AG's patents?

Elanco Tiergesundheit AG's patents average 9.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Elanco Tiergesundheit AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Elanco Tiergesundheit AG

USPTO PatentsView assignee record - 20 granted patents across 13 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Elanco ranks #14,585 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 13 technology areas.

#14,585
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.7/100): 9.9
avg claims per patent: -46%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14585 · US Corporation #14,585 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,585/49,997
PHOTO-FINISH Earthway Products
CPC-FOCUS A61P · 13 areas
INNOV-THIN 31.7/100
CLAIMS-PAR 9.9 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -46% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Earthway Products, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Elanco’s 31.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (33%) Velocity 2.5 pts (8%) Breadth 12.7 pts (40%) Claim depth 6.0 pts (19%)

Qualcomm Incorporated · highest

85
Elanco Tiergesundheit · this assignee

32
3D Lighting… · lowest

7

What this shows Elanco's Innovation Score is 31.7/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Elanco?

Each dot is one of Elanco’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Elanco’s own 9.9 claims/patent is at or below the 17.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Elanco vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Elanco's grants concentrate

Elanco Tiergesundheit AG is a focused PatentsView assignee: 13 CPC subclasses with 80% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (6 grants) versus a trough of 1 in 2021. By volume, Elanco sits between Exthera Medical Corporation and Enerpac Tool Group Corp..

Elanco's three-year grant acceleration

Elanco Tiergesundheit AG shows 3 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Exthera Medical

20
Earthway Products

20
East Tennessee St…

20
Ecofactor

20
Ellenby

20
Emergency Technol…

20
Emmanuelle Charpe…

20
Enerpac Tool Group

20
Elanco Tiergesund… ◀

20

What this shows Elanco holds 20 patents at rank #14,594, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Elanco

By rank, the assignees closest to #14,594 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Elanco's primary technology class.

Elanco's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Elanco Tiergesundheit AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	15.0%
2018	6	30.0%
2019	4	20.0%
2020	3	15.0%
2021	1	5.0%
2022	1	5.0%
2024	2	10.0%

Which technologies does Elanco Tiergesundheit AG patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 16

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

C07D - Heterocyclic Compounds 9

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 4

Y02A - Technologies FOR Adaptation TO Climate Change 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07K - Peptides 3

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 2

C07C - Acyclic OR Carbocyclic Compounds 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

A23K - Fodder 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Elanco Tiergesundheit AG's patent record in context - here's where to go next.

Elanco Tiergesundheit AG's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 80% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #14,585 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Elanco Tiergesundheit AG against Exthera Medical Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.